Literature DB >> 2971728

Structural polymorphism of the human platelet Fc gamma receptor.

R J Looney1, C L Anderson, D H Ryan, S I Rosenfeld.   

Abstract

A variable T lymphocyte proliferative response to murine IgG1 anti-T3 monoclonal antibodies, in which most North American Caucasians respond whereas a minority do not, is well established. This is most likely the result of a genetic polymorphism manifested by 1) the inability of the monocyte 40-kDa IgG FcR of some individuals to bind murine IgG1, and 2) a distinctive trimorphic pattern on IEF of the monocyte 40-kDa FcR, one form being seen in all individuals who do not respond and another form (or a combination of both forms) being seen in those who do respond. We have evaluated the IEF patterns of the platelet 40-kDa FcR and find that in every individual tested the pattern for platelet FcR correlates with that seen for the monocyte 40-kDa FcR pattern. Furthermore, the platelets of those individuals whose "nonresponder" monocyte 40-kDa FcR did not mediate a murine IgG1 anti-T3 response did not respond with an aggregation reaction to murine IgG1 immune complexes (opsonized E). In contrast, platelets from donors possessing "responder" monocytes displayed positive "aggregation" responses to E coated with murine IgG1 antibody. However, the platelet FcR structural polymorphism described earlier did not correlate with the donor-specific variability in capacity of platelets to respond functionally to aggregated human IgG described in an earlier paper. Rather, the variation in capacity of platelets from individual donors to respond functionally to aggregated human IgG was related to the quantitative expression of platelet FcR. These data indicate that the molecular mechanisms responsible for the platelet 40-kDa FcR structural polymorphism are quite different from the mechanisms governing the variation in quantitative expression of the receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971728

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Fc receptor-mediated signal transduction.

Authors:  C T Lin; Z Shen; P Boros; J C Unkeless
Journal:  J Clin Immunol       Date:  1994-01       Impact factor: 8.317

2.  Fc gamma receptor III on human neutrophils. Allelic variants have functionally distinct capacities.

Authors:  J E Salmon; J C Edberg; R P Kimberly
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions.

Authors:  Adam M Boruchov; Glenn Heller; Maria-Concetta Veri; Ezio Bonvini; Jeffrey V Ravetch; James W Young
Journal:  J Clin Invest       Date:  2005-09-15       Impact factor: 14.808

4.  The polymorphic Fc gamma receptor II gene maps to human chromosome 1q.

Authors:  H O Grundy; G Peltz; K W Moore; M S Golbus; L G Jackson; R V Lebo
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Functional polymorphism of IgG FcRII (CD32) on human neutrophils.

Authors:  J F Leeuwenberg; J G Van de Winkel; T M Jeunhomme; W A Buurman
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

6.  Mechanisms of platelet activation by a stimulatory antibody: cross-linking of a novel platelet receptor for monoclonal antibody F11 with the Fc gamma RII receptor.

Authors:  U P Naik; Y H Ehrlich; E Kornecki
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation.

Authors:  Jennifer Yeung; Benjamin E Tourdot; Pilar Fernandez-Perez; Joanne Vesci; Jin Ren; Christopher J Smyrniotis; Diane K Luci; Ajit Jadhav; Anton Simeonov; David J Maloney; Theodore R Holman; Steven E McKenzie; Michael Holinstat
Journal:  Blood       Date:  2014-08-06       Impact factor: 22.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.